{
    "Symbol": "QGEN",
    "AssetType": "Common Stock",
    "Name": "Qiagen NV",
    "Description": "QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.",
    "CIK": "1015820",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "HULSTERWEG 82, PL VENLO, NL",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "10160593000",
    "EBITDA": "364742000",
    "PERatio": "30.13",
    "PEGRatio": "1.247",
    "BookValue": "15.32",
    "DividendPerShare": "0",
    "DividendYield": "0.0294",
    "EPS": "1.52",
    "RevenuePerShareTTM": "8.87",
    "ProfitMargin": "0.0375",
    "OperatingMarginTTM": "-0.323",
    "ReturnOnAssetsTTM": "0.0175",
    "ReturnOnEquityTTM": "0.0207",
    "RevenueTTM": "1940199000",
    "GrossProfitTTM": "1437113000",
    "DilutedEPSTTM": "1.52",
    "QuarterlyEarningsGrowthYOY": "-0.056",
    "QuarterlyRevenueGrowthYOY": "0.003",
    "AnalystTargetPrice": "50.11",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "6",
    "AnalystRatingHold": "10",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "30.13",
    "ForwardPE": "18.83",
    "PriceToSalesRatioTTM": "4.526",
    "PriceToBookRatio": "2.336",
    "EVToRevenue": "4.767",
    "EVToEBITDA": "13.61",
    "Beta": "0.4",
    "52WeekHigh": "46.55",
    "52WeekLow": "34.77",
    "50DayMovingAverage": "42.67",
    "200DayMovingAverage": "42.3",
    "SharesOutstanding": "221847000",
    "DividendDate": "2024-01-30",
    "ExDividendDate": "2024-01-30"
}